Mesothelioma News

Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
The early detection test will mainly target over 45 million Americans who are at an increased risk of lung cancer due to smoking, as well […]

BLOOMFIELD, N.J., April 18, 2007 /PRNewswire-FirstCall/ — ONCONASE (ranpirnase), Alfacell Corporation’s lead drug candidate, may have potential as a chemopreventive agent, according to world-renowned mesothelioma researcher Michele Carbone M.D., Ph.D., at this week’s American Association for Cancer Research (AACR) Annual Meeting.
In a series of poster presentations, Dr. Carbone highlighted the growing worldwide problem of asbestos […]

DETROIT, April 17 /PRNewswire/ — The Barbara Ann Karmanos Cancer
Institute today announced significant scientific findings that could lead
to better treatment and therapies for cancer patients suffering from
malignant pleural mesothelioma.
Karmanos scientists presented their research at the American
Association of Cancer Research (AACR) annual meeting in Los Angeles, CA.
“We are getting closer and closer to making an impact […]

Mesothelioma is an aggressive form of lung cancer resulting from exposure to asbestos. Choosing a doctor with an established reputation in treating Mesothelioma can make all the difference in your treatment experience.
A mesothelioma diagnosis is a very serious matter and understanding your treatment options is very important. That is why consulting with your primary care […]